• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药物联合使用相关的心血管发病率和死亡率:一项全面综述。

Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review.

作者信息

Edinoff Amber N, Ellis Emily D, Nussdorf Laura M, Hill Taylor W, Cornett Elyse M, Kaye Adam M, Kaye Alan D

机构信息

Department of Psychiatry and Behavioral Medicine, Louisiana State University Health Science Center Shreveport, 1501 Kings Hwy, Shreveport, LA 71103, USA.

School of Medicine, Louisiana State University Shreveport, Shreveport, LA 71103, USA.

出版信息

Neurol Int. 2022 Mar 17;14(1):294-309. doi: 10.3390/neurolint14010024.

DOI:10.3390/neurolint14010024
PMID:35324580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8954521/
Abstract

Schizophrenia is a psychotic disorder that exists at the more extreme end of a spectrum of diseases, and significantly affects daily functioning. Cardiovascular adverse effects of antipsychotic medications are well known, and include changes in blood pressure and arrhythmias. Sudden cardiac death is the leading cause of death worldwide, and antipsychotic medications are associated with numerous cardiac side effects. A possible link exists between antipsychotic medications and sudden cardiac death. Common prescribing patterns that may influence cardiovascular events include the use of multiple antipsychotics and/or additional drugs commonly prescribed to patients on antipsychotics. The results of this review reflect an association between antipsychotic drugs and increased risk of ventricular arrhythmias and sudden cardiac death by iatrogenic prolongation of the QTc interval. QTc prolongation and sudden cardiac death exist in patients taking antipsychotic monotherapy. The risk increases for the concomitant use of specific drugs that prolong the QTc interval, such as opioids, antibiotics, and illicit drugs. However, evidence suggests that QTc intervals may not adequately predict sudden cardiac death. In considering the findings of this narrative review, we conclude that it is unclear whether there is a precise association between antipsychotic polypharmacy and sudden cardiac death with QTc interval changes. The present narrative review warrants further research on this important potential association.

摘要

精神分裂症是一种存在于一系列疾病较极端一端的精神障碍,会显著影响日常功能。抗精神病药物的心血管不良反应是众所周知的,包括血压变化和心律失常。心源性猝死是全球主要的死亡原因,抗精神病药物与众多心脏副作用相关。抗精神病药物与心源性猝死之间可能存在联系。可能影响心血管事件的常见处方模式包括使用多种抗精神病药物和/或通常给服用抗精神病药物的患者开具的其他药物。本综述的结果反映了抗精神病药物与因医源性QTc间期延长导致室性心律失常和心源性猝死风险增加之间的关联。服用抗精神病单药治疗的患者存在QTc延长和心源性猝死情况。同时使用延长QTc间期的特定药物(如阿片类药物、抗生素和非法药物)时风险会增加。然而,有证据表明QTc间期可能无法充分预测心源性猝死。考虑到本叙述性综述的结果,我们得出结论,抗精神病药物联合使用与因QTc间期变化导致的心源性猝死之间是否存在确切关联尚不清楚。本叙述性综述值得对这一重要的潜在关联进行进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ec/8954521/e80519517f1c/neurolint-14-00024-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ec/8954521/e80519517f1c/neurolint-14-00024-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ec/8954521/e80519517f1c/neurolint-14-00024-g001.jpg

相似文献

1
Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review.抗精神病药物联合使用相关的心血管发病率和死亡率:一项全面综述。
Neurol Int. 2022 Mar 17;14(1):294-309. doi: 10.3390/neurolint14010024.
2
[Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].[将精神分裂症患者中与QTc延长相关的风险降至最低。精神分裂症心脏安全小组的共识声明]
Encephale. 2002 Nov-Dec;28(6 Pt 1):552-62.
3
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].[制定重症精神疾病患者身体健康检查指南]
Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9.
4
QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy.抗精神病药单药治疗或联合用药治疗的精神分裂症患者的 QTc 间期。
CNS Spectr. 2018 Aug;23(4):278-283. doi: 10.1017/S1092852917000402. Epub 2017 Jun 29.
5
Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.抗精神病药物相关的QTc间期延长、尖端扭转型室速和猝死。
Drugs. 2002;62(11):1649-71. doi: 10.2165/00003495-200262110-00006.
6
Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.抗精神病药和抗抑郁药的致心律失常风险:老年人的影响。
Drugs Aging. 2009;26(12):997-1012. doi: 10.2165/11318880-000000000-00000.
7
Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review.抗精神病药物联合使用与校正QT间期:一项系统评价。
Can J Psychiatry. 2015 May;60(5):215-22. doi: 10.1177/070674371506000503.
8
QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study.服用典型或非典型抗精神病药物的精神病患者的QTc间期测量与代谢参数:一项初步研究。
J Clin Psychiatry. 2005 Nov;66(11):1386-91. doi: 10.4088/jcp.v66n1107.
9
Risk Stratification of QTc Prolongation in Critically Ill Patients Receiving Antipsychotics for the Management of Delirium Symptoms.使用抗精神病药物治疗谵妄症状的危重症患者QTc延长的风险分层
J Intensive Care Med. 2025 Apr;40(4):355-371. doi: 10.1177/08850666231222470. Epub 2023 Dec 21.
10
Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.抗精神病药物:QTc间期延长、尖端扭转型室速和猝死。
Am J Psychiatry. 2001 Nov;158(11):1774-82. doi: 10.1176/appi.ajp.158.11.1774.

引用本文的文献

1
Validation of a Clinical Decision Support Tool for Quantifying Risk of Torsades de Pointes in a Psychiatric Inpatient Population.一种用于量化精神科住院患者尖端扭转型室性心动过速风险的临床决策支持工具的验证
Innov Clin Neurosci. 2025 Jun 1;22(4-6):14-19. eCollection 2025 Apr-Jun.
2
Management of Bipolar Disorder in Pregnancy and Postpartum: A Clinicians' Guide.孕期及产后双相情感障碍的管理:临床医生指南。
CNS Drugs. 2025 Jul 1. doi: 10.1007/s40263-025-01202-7.
3
The Impact of Cognitive Impairment on Cardiovascular Disease.认知障碍对心血管疾病的影响。

本文引用的文献

1
Peri- and Post-Menopausal Women with Schizophrenia and Related Disorders Are a Population with Specific Needs: A Narrative Review of Current Theories.患有精神分裂症及相关障碍的绝经前后女性是有特殊需求的人群:当前理论的叙述性综述
J Pers Med. 2021 Aug 27;11(9):849. doi: 10.3390/jpm11090849.
2
Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.丁丙诺啡引起 QT 间期延长的机制不能用直接阻断 hERG 通道来解释。
PLoS One. 2020 Nov 6;15(11):e0241362. doi: 10.1371/journal.pone.0241362. eCollection 2020.
3
Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports.
J Am Coll Cardiol. 2025 Jul 1;85(25):2472-2491. doi: 10.1016/j.jacc.2025.04.057.
4
Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic Treatment.反映低多巴胺能信号传导的多位点基因谱与抗精神病药物治疗所致肥胖和心脏代谢紊乱直接相关。
Pharmaceutics. 2023 Aug 14;15(8):2134. doi: 10.3390/pharmaceutics15082134.
5
Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies.心脏疾病中的线粒体功能障碍及治疗策略
Biomedicines. 2023 May 22;11(5):1500. doi: 10.3390/biomedicines11051500.
6
The Effect of Antipsychotics and Their Combinations with Other Psychotropic Drugs on Electrocardiogram Intervals Other Than QTc among Jordanian Adult Outpatients.抗精神病药物及其与其他精神药物联合使用对约旦成年门诊患者除QTc外的心电图间期的影响。
Biomedicines. 2022 Dec 22;11(1):13. doi: 10.3390/biomedicines11010013.
20 年药物安全监测报告中氯喹和羟氯喹暴露相关的心脏不良事件。
Sci Rep. 2020 Nov 5;10(1):19199. doi: 10.1038/s41598-020-76258-0.
4
Cardiac dopamine D1 receptor triggers ventricular arrhythmia in chronic heart failure.心脏多巴胺 D1 受体在慢性心力衰竭中引发室性心律失常。
Nat Commun. 2020 Aug 31;11(1):4364. doi: 10.1038/s41467-020-18128-x.
5
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment.精神分裂症的阴性症状:识别、评估及治疗的综述与临床指南
Neuropsychiatr Dis Treat. 2020 Feb 21;16:519-534. doi: 10.2147/NDT.S225643. eCollection 2020.
6
Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice.探讨抗精神病药物增加心血管疾病风险的机制:利培酮改变了小鼠的心脏蛋白质组特征。
Pharmacol Res. 2020 Feb;152:104589. doi: 10.1016/j.phrs.2019.104589. Epub 2019 Dec 23.
7
Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps.抗精神病药物与心源性猝死:预测、管理及未来措施相关挑战的文献综述。
Psychiatry Res. 2019 Nov;281:112598. doi: 10.1016/j.psychres.2019.112598. Epub 2019 Oct 3.
8
A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments.抗精神病药物治疗安全性改善的药物遗传学干预。
Transl Psychiatry. 2019 Jul 25;9(1):177. doi: 10.1038/s41398-019-0511-9.
9
Antipsychotics and risk of natural death in patients with schizophrenia.抗精神病药物与精神分裂症患者的自然死亡风险
Neuropsychiatr Dis Treat. 2019 Jul 5;15:1863-1871. doi: 10.2147/NDT.S199748. eCollection 2019.
10
Association Between Antipsychotic Polypharmacy and Outcomes for People With Serious Mental Illness in England.抗精神病药联合用药与英国严重精神疾病患者结局的关联。
Psychiatr Serv. 2019 Aug 1;70(8):650-656. doi: 10.1176/appi.ps.201800504. Epub 2019 May 21.